NR1H4 and metabolic dysfunction-associated steatotic liver disease: Further mechanistic studies have revealed that quercetin modulates lipid metabolism in NAFLD by activating the farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor 5 (TGR5).